Don’t invest unless you’re prepared to lose all the money you invest. This is a high‑risk investment and you are unlikely to be protected if something goes wrong. Take 2 mins to learn more.

Emm bg


Emm transparent logo
emm logo

Less than 2.5% of publicly funded research is dedicated solely to reproductive health, yet 1 in 3 women will suffer from a reproductive or gynaecological health problem.

Clinical baseline data is key for tracking reproductive health, but neither consumers nor clinicians have the tools to accurately measure this.

Emm has built biometric technology to bring this data to the 1/3 of women with severe reproductive health symptoms. Their technology can monitor key metrics like volume, flow rate, cycle length and regularity to aid understanding of menstrual health.

Emm wants to empower everyone to change the quality of their life by inherently understanding their health though technology and specialist knowledge.

The next generation of menstrual healthcare is coming.

Next portfolio item